- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01453166
Brazilian Heart-Prevent Meal - A Pilot Randomized Clinical Trial
July 16, 2012 updated by: Hospital do Coracao
The Effect of Brazilian Heart Prevent Meal Program Accessible for the Population to Prevent New Cardiovascular Events: A Pilot Randomized Clinical Trial
The purpose of this study is to evaluate the effectiveness of a brazilian cardioprotective diet plan to reduce cardiovascular risk factors of new cardiovascular events.
Study Overview
Status
Completed
Conditions
Detailed Description
Cardiovascular diseases are the leading cause of mortality in both sexes in Brazil and worldwide.
Modifying risk factors such as diet and lifestyle can prevent most cases of cardiovascular disease.
This pilot trial is based on specific and traditional brazilian food.
The objective is to reduce risk factors such as obesity, high blood pressure,dyslipidemia and diabetes in patients with cardiovascular disease history.
Study Type
Interventional
Enrollment (Actual)
122
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sao Paulo, Brazil, 04005000
- Hospital do Coracao
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any coronary artery disease evidence in the past 10 years; or any ischemic stroke or TIA evidence in the past 10 years; or peripheral arterial disease in the past 10 years; or at least one of the following additional risk factors:
- Diabetes Mellitus; Hypertension; Dyslipidemia; Coronary artery disease family history;
- Asymptomatic carotid artery disease;
- Body mass index> 25 kg/m2 for adults and> 28 kg/m2 for seniors
Exclusion Criteria:
- Neurocognitive or psychiatric condition;
- Life expectancy less than 6 months (eg, metastatic malignancy or other defined as clinical trial investigators).
- Pregnancy or breast feeding.
- Hepatic impairment defined as elevated liver enzymes above three times the upper limit of normal
- Renal impairment defined as creatinine values higher than 1.5 mg/dL.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1
Nutrient profile of the diets used was based on the Brazilian guidelines to cardiovascular disease treatment.The main difference between this group involves a Brazilian version of accessible and energy density concept dietary therapy to cardiovascular diseases.
Furthermore, it explores a set of tools and educational materials that help the patient understand and follow the principles of balanced and healthy diet weekly session with the dietitians which could be in person, by phone or in a gourmet shop.
During attendances at the gourmet shop, patients received tips for eating in restaurants, instruction on label reading and a list of typical foods.
The menus were based on typical foods consumed in Brazil, all foods included in the menu were low-cost and widely available at local markets
|
Nutrient profile of the diets used was based on the Brazilian guidelines to cardiovascular disease treatment.The main difference between this group involves a Brazilian version of accessible and energy density concept dietary therapy to cardiovascular diseases.
Furthermore, it explores a set of tools and educational materials that help the patient understand and follow the principles of balanced and healthy diet weekly session with the dietitians which could be in person, by phone or in a gourmet shop.
During attendances at the gourmet shop, patients received tips for eating in restaurants, instruction on label reading and a list of typical foods.
The menus were based on typical foods consumed in Brazil, all foods included in the menu were low-cost and widely available at local markets
Other Names:
|
|
Experimental: Group 2
Group B received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A, but customized by the integration of mediterranean typical foods (e.g.
olive oil and nuts).
The difference between groups B and C was the number of sessions with the dietician.
Group B received weekly sessions, which could be in person or by phone, and group C had monthly in person sessions
|
received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A, but customized by the integration of mediterranean typical foods (e.g.
olive oil and nuts).
The difference between groups B and C was the number of sessions with the dietician.
Group B received weekly sessions, which could be in person or by phone, and group C had monthly in person sessions
Other Names:
|
|
Experimental: Group 3
Group C received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A and B, but customized by the integration of mediterranean typical foods (e.g.
olive oil and nuts) at the same of group B. The difference of group C was the number of sessions with the dietician.
That happen monthly in person sessions.
|
received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A and B, but customized by the integration of mediterranean typical foods (e.g.
olive oil and nuts) at the same of group B. The difference of group C was the number of sessions with the dietician.
That happen monthly in person sessions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Systolic Blood Pressure
Time Frame: 12 weeks
|
Change From Baseline in systolic blood pressure
|
12 weeks
|
|
Total Cholesterol
Time Frame: 12 weeks
|
Change From Baseline in total Cholesterol
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: 12 weeks
|
Change From Baseline in weight
|
12 weeks
|
|
Waist Circumference
Time Frame: 12 weeks
|
Change From Baseline in wais circumference
|
12 weeks
|
|
Blood Glucose
Time Frame: 12 weeks
|
Change From Baseline in blood glucose
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Bernardete Weber, PhD, Hospital do Coracao
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
January 1, 2012
Study Registration Dates
First Submitted
October 11, 2011
First Submitted That Met QC Criteria
October 13, 2011
First Posted (Estimate)
October 17, 2011
Study Record Updates
Last Update Posted (Estimate)
July 19, 2012
Last Update Submitted That Met QC Criteria
July 16, 2012
Last Verified
July 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01/2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on Brazilian heart-prevent meal
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedEndometrial Cancer | SurvivorshipUnited States
-
Hippocration General HospitalCompletedCoronary Artery Disease | Atherosclerosis | Endothelial Dysfunction | Oxidative Stress | HMG-CoA Reductase Inhibitor ToxicityGreece
-
University of LeicesterUniversity of Leeds; University of Oxford; University of ManchesterRecruitingDiabetes Mellitus, Type 2 | Heart Failure, Diastolic | Heart Failure With Preserved Ejection Fraction | Diabetes Mellitus Type 2 in Obese | Obesity Adult OnsetUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeTerminatedCardiovascular DiseasesUnited Kingdom